Cargando…

HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa

BACKGROUND: Hidradenitis suppurativa (HS) is a chronic, relapsing, inflammatory skin disease characterized by painful inflamed nodules, recurrent abscesses and fistulas located in apocrine gland–bearing body sites. The negative impact of HS on patient's quality of life (QoL) has been reported t...

Descripción completa

Detalles Bibliográficos
Autores principales: Peris, K., Lo Schiavo, A., Fabbrocini, G., Dini, V., Patrizi, A., Fusano, M., Bianchi, L., Guanziroli, E., Guarneri, C., Parodi, A., Bertoldi, A., Musumeci, M.L., Offidani, A., Rongioletti, F., Pistone, G., Malara, G., Potenza, C., Casari, A., Franchi, C., Ardigò, M., Cusano, F., Stingeni, L., Amerio, P., Mancini, L.L., Prignano, F., Deboli, T., Gualberti, G., Saragaglia, V., Bettoli, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593467/
https://www.ncbi.nlm.nih.gov/pubmed/30633405
http://dx.doi.org/10.1111/jdv.15425
_version_ 1783430052568891392
author Peris, K.
Lo Schiavo, A.
Fabbrocini, G.
Dini, V.
Patrizi, A.
Fusano, M.
Bianchi, L.
Guanziroli, E.
Guarneri, C.
Parodi, A.
Bertoldi, A.
Musumeci, M.L.
Offidani, A.
Rongioletti, F.
Pistone, G.
Malara, G.
Potenza, C.
Casari, A.
Franchi, C.
Ardigò, M.
Cusano, F.
Stingeni, L.
Amerio, P.
Mancini, L.L.
Prignano, F.
Deboli, T.
Gualberti, G.
Saragaglia, V.
Bettoli, V.
author_facet Peris, K.
Lo Schiavo, A.
Fabbrocini, G.
Dini, V.
Patrizi, A.
Fusano, M.
Bianchi, L.
Guanziroli, E.
Guarneri, C.
Parodi, A.
Bertoldi, A.
Musumeci, M.L.
Offidani, A.
Rongioletti, F.
Pistone, G.
Malara, G.
Potenza, C.
Casari, A.
Franchi, C.
Ardigò, M.
Cusano, F.
Stingeni, L.
Amerio, P.
Mancini, L.L.
Prignano, F.
Deboli, T.
Gualberti, G.
Saragaglia, V.
Bettoli, V.
author_sort Peris, K.
collection PubMed
description BACKGROUND: Hidradenitis suppurativa (HS) is a chronic, relapsing, inflammatory skin disease characterized by painful inflamed nodules, recurrent abscesses and fistulas located in apocrine gland–bearing body sites. The negative impact of HS on patient's quality of life (QoL) has been reported to be greater than other dermatologic conditions as psoriasis and atopic eczema, and its improvement is an important goal in disease management. Nowadays, there are no specific validated QoL instruments available for HS and generic dermatologic questionnaires are used. OBJECTIVE: The objective of this study was to demonstrate the validity, reliability and responsiveness of HIDRAdisk, a new innovative tool designed for rapid assessment of HS burden and, at the same time, an intuitive graphic visualization of the measurement outcome. METHODS: A multicentre, longitudinal, observational study was conducted to validate the HIDRAdisk compared with other validated questionnaires [Skindex‐16, Dermatology Life Quality Index (DLQI), Work Productivity and Activity Impairment–General Health (WPAI:GH)] and to evaluate its correlation with disease severity in Italian patients with any degree of HS severity, as measured by Hurley stage and HS Physician Global Assessment (HS‐PGA). RESULTS: A total of 140 patients (59% women; mean age 34.9 ± 11.0 years) were enrolled in 27 dermatologic centres. HIDRAdisk showed a strong correlation with Skindex‐16 and DLQI, and a good one with WPAI:GH (correlation coefficient: 0.7568, 0.6651 and 0.5947, respectively) and a statistically significant correlation with both Hurley stage and HS‐PGA. Very good internal consistency (Cronbach coefficient >0.80; intraclass correlation coefficient >0.6), with correlation between the 10 items, good test–retest reliability (Spearman correlation coefficient, 0.8331; P < 0.0001) and responsiveness to changes were demonstrated. CONCLUSION: Our study shows that HIDRAdisk, a short and innovative visual HS QoL instrument, has been psychometrically validated in Italian language and it may help improve the management of HS once implemented in routine clinical practice.
format Online
Article
Text
id pubmed-6593467
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65934672019-07-10 HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa Peris, K. Lo Schiavo, A. Fabbrocini, G. Dini, V. Patrizi, A. Fusano, M. Bianchi, L. Guanziroli, E. Guarneri, C. Parodi, A. Bertoldi, A. Musumeci, M.L. Offidani, A. Rongioletti, F. Pistone, G. Malara, G. Potenza, C. Casari, A. Franchi, C. Ardigò, M. Cusano, F. Stingeni, L. Amerio, P. Mancini, L.L. Prignano, F. Deboli, T. Gualberti, G. Saragaglia, V. Bettoli, V. J Eur Acad Dermatol Venereol Acne ‐ Rosacea BACKGROUND: Hidradenitis suppurativa (HS) is a chronic, relapsing, inflammatory skin disease characterized by painful inflamed nodules, recurrent abscesses and fistulas located in apocrine gland–bearing body sites. The negative impact of HS on patient's quality of life (QoL) has been reported to be greater than other dermatologic conditions as psoriasis and atopic eczema, and its improvement is an important goal in disease management. Nowadays, there are no specific validated QoL instruments available for HS and generic dermatologic questionnaires are used. OBJECTIVE: The objective of this study was to demonstrate the validity, reliability and responsiveness of HIDRAdisk, a new innovative tool designed for rapid assessment of HS burden and, at the same time, an intuitive graphic visualization of the measurement outcome. METHODS: A multicentre, longitudinal, observational study was conducted to validate the HIDRAdisk compared with other validated questionnaires [Skindex‐16, Dermatology Life Quality Index (DLQI), Work Productivity and Activity Impairment–General Health (WPAI:GH)] and to evaluate its correlation with disease severity in Italian patients with any degree of HS severity, as measured by Hurley stage and HS Physician Global Assessment (HS‐PGA). RESULTS: A total of 140 patients (59% women; mean age 34.9 ± 11.0 years) were enrolled in 27 dermatologic centres. HIDRAdisk showed a strong correlation with Skindex‐16 and DLQI, and a good one with WPAI:GH (correlation coefficient: 0.7568, 0.6651 and 0.5947, respectively) and a statistically significant correlation with both Hurley stage and HS‐PGA. Very good internal consistency (Cronbach coefficient >0.80; intraclass correlation coefficient >0.6), with correlation between the 10 items, good test–retest reliability (Spearman correlation coefficient, 0.8331; P < 0.0001) and responsiveness to changes were demonstrated. CONCLUSION: Our study shows that HIDRAdisk, a short and innovative visual HS QoL instrument, has been psychometrically validated in Italian language and it may help improve the management of HS once implemented in routine clinical practice. John Wiley and Sons Inc. 2019-03-05 2019-04 /pmc/articles/PMC6593467/ /pubmed/30633405 http://dx.doi.org/10.1111/jdv.15425 Text en © 2019 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Acne ‐ Rosacea
Peris, K.
Lo Schiavo, A.
Fabbrocini, G.
Dini, V.
Patrizi, A.
Fusano, M.
Bianchi, L.
Guanziroli, E.
Guarneri, C.
Parodi, A.
Bertoldi, A.
Musumeci, M.L.
Offidani, A.
Rongioletti, F.
Pistone, G.
Malara, G.
Potenza, C.
Casari, A.
Franchi, C.
Ardigò, M.
Cusano, F.
Stingeni, L.
Amerio, P.
Mancini, L.L.
Prignano, F.
Deboli, T.
Gualberti, G.
Saragaglia, V.
Bettoli, V.
HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa
title HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa
title_full HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa
title_fullStr HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa
title_full_unstemmed HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa
title_short HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa
title_sort hidradisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa
topic Acne ‐ Rosacea
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593467/
https://www.ncbi.nlm.nih.gov/pubmed/30633405
http://dx.doi.org/10.1111/jdv.15425
work_keys_str_mv AT perisk hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT loschiavoa hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT fabbrocinig hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT diniv hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT patrizia hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT fusanom hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT bianchil hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT guanzirolie hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT guarneric hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT parodia hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT bertoldia hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT musumeciml hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT offidania hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT rongiolettif hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT pistoneg hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT malarag hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT potenzac hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT casaria hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT franchic hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT ardigom hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT cusanof hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT stingenil hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT ameriop hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT mancinill hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT prignanof hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT debolit hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT gualbertig hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT saragagliav hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa
AT bettoliv hidradiskvalidationofaninnovativevisualtooltoassesstheburdenofhidradenitissuppurativa